NASDAQ$HSIC

Henry Schein Inc · Q3 2024 earnings

Q3 2024 earnings · · Investor relations

Briefing

Henry Schein reported financial results for the third quarter ended September 28, 2024, and increased its full-year non-GAAP EPS guidance.

Henry Schein's third-quarter results for 2024 showed a slight increase in total net sales, driven by acquisitions and the successful implementation of their BOLD+1 Strategic Plan. The company's GAAP diluted EPS was $0.78, and non-GAAP diluted EPS was $1.22. They have increased their full-year non-GAAP EPS guidance to $4.74 to $4.82.

  • Third-quarter GAAP diluted EPS was $0.78, and non-GAAP diluted EPS was $1.22.
  • Total net sales for the quarter were $3.2 billion, a 0.4% increase compared to Q3 2023.
  • Operating cash flow for the quarter was $151 million.
  • The company increased its 2024 full-year non-GAAP EPS guidance to $4.74 to $4.82.

Headline financials

Total Revenue

$3.17B

Previous: $3.16B+0.4%
EPS

$0.78

Previous: $1.32-40.9%
Capital Expenditures

-$44M

No prior period
Free Cash Flow

$99M

Previous: $137M-27.7%
Net Income

$99M

Previous: $137M-27.7%
Operating Income

$157M

Previous: $200M-21.5%
Gross Profit

$993M

Previous: $995M-0.2%
Total Assets

$10.6B

Previous: $9.81B+8.1%
Stock-Based Comp

$10M

Previous: $14M-28.6%

Revenue & EPS history

Henry Schein · Revenue · Quarterly

$3.17B

Q3 2024+0.4%vs Q3 2023
Beat estimate in 8 of 15 quarters(53%)
ActualEstimate

Revenue by segment

Henry Schein · $3B total across 2 segments · Q3 2023

  • Global Dental
    $1.9B+5.6%
  • Global Medical
    $1.1B+0.0%

Forward guidance

Henry Schein updated its full-year 2024 financial guidance. Total sales growth is now expected to be 4% to 5% over 2023. Non-GAAP diluted EPS is expected to be $4.74 to $4.82. Adjusted EBITDA is expected to grow in the low-double-digit percentages versus 2023.

Tailwinds

  • 2024 total sales growth is now expected to be 4% to 5% over 2023.
  • 2024 non-GAAP diluted EPS attributable to Henry Schein, Inc. is now expected to be $4.74 to $4.82.
  • Reflects growth of 5% to 7% compared with 2023 non-GAAP diluted EPS of $4.50.
  • 2024 Adjusted EBITDA is expected to grow in the low-double-digit percentages versus 2023 Adjusted EBITDA.
  • Guidance assumes that foreign currency exchange rates remain generally consistent with current levels and that end markets remain consistent with current market conditions.

Headwinds

  • Guidance does not include the impact of potential future acquisitions and share repurchases.
  • Guidance does not include restructuring and integration expenses.
  • Guidance does not include amortization expense of acquired intangible assets.
  • Guidance does not include contingent consideration revaluation adjustments.
  • Guidance does not include certain expenses directly associated with the cyber incident or any related insurance claim recovery.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q3 2024

Historical avgQ3 2024

-0.4%

Avg return

Earnings day

-0.5%

Avg return

5 days after

-0.6%

Avg return

30 days after

45%

31 / 69 earnings

Positive

+11.1%

Q4 2021

Best reaction

-8.5%

Q3 2017

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+3.3%-1.6%+4.6%
Q4 2025+5.8%+2.3%-8.5%
Q3 2025+10.9%+11.2%+13.5%
Q1 2025+2.0%+5.1%+7.8%
Q4 2024-2.3%-7.0%-10.6%
Q3 2024-3.2%-6.0%+0.2%
Q2 2024-5.4%-0.9%+0.4%
Q1 2024+6.2%+7.0%+0.1%
Q4 2023-5.1%-4.6%-6.3%
Q3 2023+7.5%+7.3%+15.5%
Q2 2023-2.8%-1.8%-5.1%
Q1 2023-4.5%-4.2%-6.1%
Q4 2022-6.2%-7.5%-12.8%
Q3 2022+1.8%+6.2%+21.2%
Q2 2022-4.9%-3.8%-7.3%
Q1 2022+7.4%+6.6%+5.6%
Q4 2021+11.1%+10.1%+14.5%
Q3 2021+3.0%+4.5%-6.7%
Q2 2021-4.8%-5.2%-2.3%
Q1 2021+6.6%+8.9%+5.3%
Q4 2020-8.5%-6.5%-5.3%
Q3 2020-5.0%-3.0%+4.6%
Q2 2020-5.3%-4.4%-6.9%
Q1 2020+0.4%+2.9%+20.6%
Q4 2019-8.4%-14.4%-38.9%
Q3 2019+4.4%+4.8%+5.2%
Q2 2019-3.2%-2.3%-4.2%
Q1 2019+8.6%+8.9%+8.6%
Q4 2018-5.0%-5.2%-5.2%
Q3 2018+3.1%+0.8%+3.3%
Q2 2018-0.5%-3.6%+0.5%
Q1 2018-6.1%-4.4%-6.7%
Q4 2017-1.2%-2.1%-5.2%
Q3 2017-8.5%-13.6%-13.0%
Q2 2017-7.7%-7.2%-4.9%
Q1 2017+0.6%+0.3%+5.2%
Q4 2016+2.7%+3.2%+2.0%
Q3 2016+4.6%+6.2%+1.7%
Q2 2016-7.1%-8.4%-8.6%
Q1 2016-2.5%
Q4 2015+7.0%
Q3 2015+1.1%
Q2 2015-1.9%
Q1 2015-0.4%
Q4 2014+0.9%
Q3 2014+5.4%
Q2 2014-1.8%
Q1 2014-1.7%
Q4 2013+0.1%
Q3 2013-2.6%
Q2 2013-0.3%
Q1 2013+2.1%
Q4 2012-2.2%
Q3 2012-0.6%
Q2 2012+1.8%
Q1 2012+2.4%
Q4 2011+3.4%
Q3 2011-6.4%
Q2 2011-2.3%
Q1 2010-2.0%
Q1 2011+0.5%
Q4 2010-3.9%
Q1 2009-3.9%
Q4 2008-3.9%
Q3 2009-4.1%
Q3 2010-4.1%
Q2 2010+2.1%
Q4 2009+2.1%
Q2 2009+2.1%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro